<DOC>
	<DOCNO>NCT01265420</DOCNO>
	<brief_summary>This study evaluate efficacy safety clostridial collagenase injection treatment Dupuytren 's contracture thumb first web space . The investigator hypothesis clostridial collagenase safety significantly different demonstrate Phase III clinical trial , effective significantly reduce degree thumb contracture .</brief_summary>
	<brief_title>Efficacy Safety Xiaflex Injection Treatment Dupuytren 's Contracture Thumb</brief_title>
	<detailed_description />
	<mesh_term>Contracture</mesh_term>
	<mesh_term>Dupuytren Contracture</mesh_term>
	<criteria>Adult subject ( &gt; 18 year ) either gender MP and/or IP joint contracture palpable cord &gt; 20 degree thumb First web space contracture palpable cord due Dupuytren 's contracture Prior surgical , percutaneous needle aponeurotomy Xiaflex treatment Dupuytren 's contracture thumb . Any subject use anticoagulant therapy low dose aspirin ( 150mg/day ) . Any subject opinion MD investigator chronic , severe terminal medical illness would make unsuitable study participation . Any subject know allergy Xiaflex ( Clostridial collagenase ) . Pregnant nursing female Any subject conform study visit schedule</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Dupuytren</keyword>
	<keyword>Dupuytren 's Disease</keyword>
</DOC>